A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients' risk of having organ injury or developing acute respiratory distress syndrome, a serious condition ...
May 19, 2024
0
73
Rutgers researchers, aided by international collaborators, have tracked the devastation war has made on Ukraine's hospital system.
May 17, 2024
0
0
A new analysis of a controversial study affirms something menopause experts have long argued: For many women, the benefits of short-term hormone replacement therapy outweigh their risks.
May 16, 2024
0
0
After the Supreme Court overturned Roe v. Wade nearly two years ago, paving the way for states to usher in new restrictions on abortion, doctors started seeing more young adults seeking vasectomies or getting their tubes ...
May 16, 2024
0
0
Since the earliest days of the pandemic, health officials have gauged the threat of COVID-19 by comparing it to the flu.
May 16, 2024
0
50
A Northwestern Medicine study shows that technology alone can't replace the human touch to produce meaningful weight loss in obesity treatment. The study, titled "An Adaptive Behavioral Intervention for Weight Loss Management: ...
May 14, 2024
0
71
A new study presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May), and published simultaneously in JAMA, has concluded that text messages with financial incentives can help men who are living with ...
May 14, 2024
0
1
The addition of cardiovascular biomarkers to established risk factors leads to a small improvement in risk prediction of cardiovascular disease, according to a study published online May 13 in the Journal of the American ...
May 14, 2024
0
0
Researchers at Brigham and Women's Hospital and Duke University showed that a genetic variant, present in 3-4% of self-identified Black individuals in the U.S., increases the risk for both heart failure and death and contributes ...
May 12, 2024
0
44
When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug ...
May 9, 2024
0
1
